2019-09-10T00:00:00Z

FDA – Warning Letter

Pharmaceutical Guidanace April 14, 2020 USFDA WARNING LETTER Comments Off on FDA – Warning Letter 1,133 Views

FDA – Warning Letter September 10, 2019

For FDA Warning Letter Click Here –

Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.

For more FDA warning Letter Visit: https://pharmaguidances.com/shop/guideline/usfda-warning-letter/

FDA – Warning Letter

About Pharmaceutical Guidanace

Ms. Abha Maurya is the Author and founder of pharmaceutical guidance, he is a pharmaceutical Professional from India having more than 18 years of rich experience in pharmaceutical field. During his career, he work in quality assurance department with multinational company’s i.e Zydus Cadila Ltd, Unichem Laboratories Ltd, Indoco remedies Ltd, Panacea Biotec Ltd, Nectar life Science Ltd. During his experience, he face may regulatory Audit i.e. USFDA, MHRA, ANVISA, MCC, TGA, EU –GMP, WHO –Geneva, ISO 9001-2008 and many ROW Regularities Audit i.e.Uganda,Kenya, Tanzania, Zimbabwe. He is currently leading a regulatory pharmaceutical company as a head Quality. You can join him by Email, Facebook, Google+, Twitter and YouTube

Check Also

Pharma FDA Warning Letter for Derma Pharm A/S MARCS-CMS – November 26

Teligent Pharma, Inc. MARCS-CMS 587592 — November 26, 2019 For FDA Warning Letter Click Here …

FDA – Warning Letter